Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab Maintenance in RAS WT mCRC
NCT03300609Phase 3Terminated
- Sponsor
- University of Southern California
- Start
- Feb 2018
- Primary completion
- Oct 2019
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of panitumumab in colorectal cancer (CRC), sponsored by University of Southern California. Started Feb 2018; status: terminated.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03300609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03300609.